Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nocturnal free fatty acid measurements and propranolol beta-blockade in obese and lean men
NL-OMON21331Not yet recruiting
- Sponsor
- Academic Medical Center
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of propranolol (2 arms), sponsored by Academic Medical Center. Primary endpoint: Percent and/or absolute changes in nocturnal free fatty acid levels with or without beta-blockade. Planned start Dec 2008; status: not yet recruiting.
02
Drugs
propranolol
Beyond the preview
Go deeper on NL-OMON21331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21331.